AboutZhongke Meiling Cryogenics Company Limited
MELING BIOLOGY & MEDICAL, or Zhongke Meiling Cryogenics Co., Ltd., is a joint venture which was founded in 2002 by Hefei Meling Co., Ltd. and Chinese Academy of Sciences. We are awarded as a national new high-tech enterprise, engaging in life science, family health and cold chain solutions.
Our company main products include lab / medical refrigerator and freezer, ultra low temperature freezer, blood bank refrigerator, inventory rack/box, family health items, professional cold room, and bio-bank management. We are dedicated in providing solutions including MIBS intelligent biobank, wireless intelligent temperature monitoring, cold-chain storage, blood security solution, and CO2/liquid nitrogen backup system. Meling is aiming to research and develop cryogenic preservation service for medical health care, disease control and epidemic prevention, blood bank system, scientific research institutions, bio-pharmaceutical factories, genetic engineering, and life science. We have the perfect service system and have gotten international ISO, CE, UL approval. Our products have been exported to more than 50 countries including Europe, America, Asia, Latin America, and Africa.
The company has a research and development center of more than 5,000 square meters, a main workshop of more than 60,000 square meters, an internationally leading production line of automatic low-temperature equipment, a testing line, and a well-equipped pilot workshop and type laboratory. After 17 years of intensive cultivation in the professional field, we have built a high-quality research and development team, and obtained a number of scientific and technological innovation achievements, invention patents and utility model patented technology. Among them, "new mixed working medium throttling refrigeration technology and its application" with independent intellectual property rights won the second prize of National Technical Invention and the first prize of China Refrigeration Society.
The company officially landed on the new third board on February 24, 2016. At present, it is carrying out strategic transformation: from "cryogenic equipment field" to "biomedical field", from "terminal product manufacturer" to "product + service provider", from "technology-oriented" to "technology-based, product-based, market-oriented and user-centered". Through this series of transformation, it will create better products for users, give more benefits to customers, provide better platform for employees, and create higher value for shareholders.
MELING BIOLOGY & MEDICAL, Caring about the life, Caring for the health. Sailing off for the life sciences！